Research Article

Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease

Table 3

Treatment strategies of patients.

Initial treatment modalityHCC on NAFLD (n = 56)HCC on ALD (n = 173)HCC on HBV (n = 393) value

TACE, n (%)28 (50.0%)112 (64.7%)216 (55%)0.027
Surgical resection, n (%)11 (19.6%)12 (6.9%)56 (14.2%)0.014
RFA, n (%)0 (0.0%)13 (7.5%)23 (5.9%)0.111
Sorafenib, n (%)9 (16.1%)6 (3.5%)37 (9.4%)0.006
Best supportive care, n (%)8 (14.3%)30 (17.3%)61 (15.5%)0.811

HCC: hepatocellular carcinoma; NAFLD: nonalcoholic fatty liver disease; ALD: alcoholic liver disease; HBV: hepatitis B virus; TACE: transcatheter arterial chemoembolization; RFA: radiofrequency ablation.